首站-论文投稿智能助手
典型文献
Cryo-EM structure of the type Ⅲ-E CRISPR-Cas effector gRAMP in complex with TPR-CHAT
文献摘要:
Dear Editor, Prokaryotes and viruses have been engaged in an evolutionary struggle for billions of years.1 Bacteria and archaea employ clustered regularly interspaced short palindromic repeats(CRISPR)-CRISPR-associated(Cas)adaptive immune systems to protect against viral infection.2 The CRISPR-Cas locus consists of two parts:CRISPR and Cas genes.According to the latest phylogenetic classification,the CRISPR-Cas system can be divided into two classes,which can be further subdivided into six types.3 Class 1 CRISPR-Cas systems are characterized by a multiprotein effector,and consist of type Ⅰ,Ⅲ,and Ⅳ CRISPR-Cas systems.Class 2 CRISPR-Cas systems feature a single nuclease protein,and consist of type Ⅱ,Ⅴ,and Ⅵ CRISPR-Cas systems.The type Ⅱ Cas9 and type Ⅴ Cas12 systems have been engineered as genome editing tools,and they have been successfully applied in a broad range of organisms.4,5 Compared to Cas9,the type ⅥCas13 system exhibits RNA-guided RNase activity and the property of nonspecific cutting.6 Recently,a new subtype of CRISPR-Cas,type Ⅲ-E,3 has been identified and named gRAMP7 or Cas7-11.8 Unlike the traditional effectors of the type Ⅲ CRISPR-Cas system,gRAMP is a single effector protein with four Cas7 proteins and one Cas11 protein fused together.Given its unique architecture and specific cleavage activity,gRAMP is expected to be engineered as a powerful RNA editing tool.8 Interestingly,a gene encoding the caspase-like peptidase TPR-CHAT often co-occurs with gRAMP gene clusters.3 TPR-CHAT interacts directly with gRAMP,7 indicat-ing a functional relationship between the CRISPR-Cas system and caspase peptidase.However,the exact mechanism of the recognition and cleavage of target ssRNA by gRAMP from Candidatus"Scalindua brodae"(Sb-gRAMP),7 as well as the molecular architecture of the CRISPR-guided caspase complex,remain unclear.
文献关键词:
作者姓名:
Shuo Wang;Minghui Guo;Yuwei Zhu;Zhiying Lin;Zhiwei Huang
作者机构:
HIT Center for Life Sciences,School of Life Science and Technology,Harbin Institute of Technology,Harbin,Heilongjiang,China;Westlake Center for Genome Editing,Westlake Laboratory of Life Sciences and Biomedicine,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China
引用格式:
[1]Shuo Wang;Minghui Guo;Yuwei Zhu;Zhiying Lin;Zhiwei Huang-.Cryo-EM structure of the type Ⅲ-E CRISPR-Cas effector gRAMP in complex with TPR-CHAT)[J].细胞研究(英文版),2022(12):1128-1131
A类:
gRAMP, Prokaryotes,gRAMP7,Cas7,Cas11,ssRNA,Scalindua,brodae
B类:
Cryo,EM,structure,CRISPR,complex,TPR,CHAT,Dear,Editor,viruses,have,been,engaged,evolutionary,struggle,billions,years,Bacteria,archaea,employ,clustered,regularly,interspaced,short,palindromic,repeats,associated,adaptive,immune,systems,protect,against,viral,infection,locus,consists,two,parts,genes,According,latest,phylogenetic,classification,can,into,classes,which,further,subdivided,six,types,Class,characterized,by,multiprotein,feature,single,nuclease,Cas9,Cas12,engineered,genome,editing,tools,they,successfully,applied,broad,range,organisms,Compared,Cas13,exhibits,guided,RNase,activity,property,nonspecific,cutting,Recently,new,subtype,has,identified,named,Unlike,traditional,effectors,four,proteins,one,fused,together,Given,unique,architecture,cleavage,expected,powerful,Interestingly,encoding,caspase,peptidase,often,occurs,clusters,interacts,directly,indicat,functional,relationship,between,However,exact,mechanism,recognition,target,from,Candidatus,Sb,well,molecular,remain,unclear
AB值:
0.483141
相似文献
CRISPR/Cas9-mediated genome editing reveals 12 testis-enriched genes dispensable for male fertility in mice
Yuki Oyama;Haruhiko Miyata;Keisuke Shimada;Yoshitaka Fujihara;Keizo Tokuhiro;Thomas X Garcia;Martin M Matzuk;Masahito Ikawa-Graduate School of Pharmaceutical Sciences,Osaka University,Suita,Osaka 565-0871,Japan;Department of Experimental Genome Research,Research Institute for Microbial Diseases,Osaka University,Suita,Osaka 565-0871,Japan;Department of Bioscience and Genetics,National Cerebral and Cardiovascular Center,Suita,Osaka 564-8565,Japan;Department of Genome Editing,Institute of Biomedical Science,Kansai Medical University,Hirakata,Osaka 573-1191,Japan;Center for Drug Discovery,Baylor College of Medicine,Houston,TX 77030,USA;Department of Pathology and Immunology,Baylor College of Medicine,Houston,TX 77030,USA;Department of Biology and Biotechnology,University of Houston-Clear Lake,Houston,TX 77058,USA;The Institute of Medical Science,The University of Tokyo,Minato-ku,Tokyo 108-8639,Japan
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。